Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...
The COCOON trial assessed prophylactic dermatologic regimens in NSCLC patients treated with amivantamab and lazertinib, showing reduced AEs and improved quality of life. Prophylactic treatment ...
Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...
The device acts on the supraorbital nerve and supratrochlear nerve, the nerves that transmit migraine pain. The Food and Drug Administration (FDA) has cleared WAT Medical’s HeadaTerm 2 as an ...
The Cambridge Prophylactic Cryotherapy Protocol was developed with the rationale of preventing retinal detachment related to giant retinal tear, to which these patients are so prone. We have ...
Dr. Costa addresses the primary clinician concern regarding BCMA-directed T-cell engagers: infection risk. Early trials ...
Gene therapy for hemophilia B allowed almost three-fourths of patients to discontinue prophylactic factor IX therapy with no increase in bleeding, results of the pivotal BENEGENE-2 trial showed. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results